Walmart is set to replace Astrazeneca on the Nasdaq-100 on January 20. This change comes as Astrazeneca’s market capitalization has decreased. The Nasdaq-100 index is a benchmark for tracking the performance of the largest non-financial companies listed on the Nasdaq stock exchange. Walmart’s inclusion in the index reflects its strong financial performance and market position.

Read more at Investing.com: Walmart to replace Astrazeneca on Nasdaq-100 on Jan 20